SCHEMBL7726271

SCHEMBL7726271

CCOC(=O)C1=C(c2cccc(F)c2NC(=O)C(C)(C)C)CCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 4/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NLRP3 Q96P20 1/20 0.40
HTT P42858 3/20 0.38
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
DHODH Q02127 2/20 0.36
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
TSHR P16473 3/20 0.34
SLC6A3 Q01959 2/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6641275 0.83 NLRP3 (0.39) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL5662430 0.83 KDM4E (0.46) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL2107755 0.80 ALOX5 (0.43) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL2108834 0.78 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL2108336 0.78 ALOX5 (0.43) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL7722875 0.76 NPC1 (0.41) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL17517033 0.71 BRD4 (0.41) ALDH1A1KDM4EHPGDL3MBTL1HTT
SCHEMBL988060 0.71 TP53 (0.45) KDM4EMAPTHTTLMNANPC1
SCHEMBL12666585 0.70 L3MBTL1 (0.52) ALDH1A1KDM4EMAPTL3MBTL1NLRP3
SCHEMBL2620013 0.69 ALOX5 (0.48) ALDH1A1SMN1; SMN2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed